Magnesio Solfato Bioindustria L.I.M.

Magnesium sulfate, the active ingredient in Magnesio Solfato Bioindustria L.I.M., is an electrolyte supplement presented as an injection solution for intravenous use. It treats magnesium deficiency‑related conditions such as hypomagnesemia, eclampsia, and cardiac arrhythmias in hospitalized patients.

GNH USA supplies Magnesio Solfato Bioindustria L.I.M. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Magnesium sulfate is used to replenish magnesium ions in clinical situations involving electrolyte imbalance or magnesium‑dependent cardiac disturbances. - Hypomagnesemia: restores serum magnesium levels and prevents neuromuscular irritability. - Eclampsia/Pre‑eclampsia: reduces risk of seizures by correcting magnesium deficiency. - Torsades de pointes: stabilizes cardiac repolarization and terminates ventricular tachyarrhythmias. - Cardiac arrhythmias related to magnesium deficiency: improves conduction and reduces ectopic activity. - Magnesium supplementation in critical care: supports metabolic functions and membrane stability in critically ill patients.

Intravenous magnesium sulfate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Flushing: transient warmth and redness of the skin. - Nausea: mild stomach upset. - Hypotension: temporary drop in blood pressure. - Injection site pain: discomfort at the infusion site.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium causing neuromuscular weakness and cardiac depression. - Respiratory depression: reduced breathing effort, potentially requiring ventilation. - Allergic reaction: anaphylaxis with rash, swelling, or bronchospasm.

When using intravenous magnesium sulfate, clinicians should observe specific safety measures to minimize risks. - Renal function: assess kidney function because impaired excretion can lead to accumulation. - Cardiac monitoring: continuously monitor ECG and blood pressure during infusion. - Concomitant calcium blockers: avoid simultaneous high‑dose calcium channel blockers to prevent additive cardiac effects. - Neuromuscular disease: use caution in patients with myasthenia gravis or severe muscle weakness. - Pregnancy: consider fetal monitoring when administered to pregnant women. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several medications, altering their efficacy or safety profile.

Major Interactions (Avoid): - Calcium channel blockers: may potentiate hypotensive and cardiac effects. - Neuromuscular blocking agents: can enhance muscle relaxation and prolong paralysis. - Digoxin: increased risk of arrhythmias due to altered electrolyte balance.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: reduced absorption and efficacy. - Loop diuretics: additive risk of electrolyte disturbances. - Anticoagulants (warfarin): possible enhancement of anticoagulant effect.